{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T07:19:01Z","timestamp":1726039141048},"publisher-location":"Cham","reference-count":47,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030163716"},{"type":"electronic","value":"9783030163730"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-16373-0_11","type":"book-chapter","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T15:02:41Z","timestamp":1564498961000},"page":"143-153","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Meta-analysis of Polymyxin Use in Patients"],"prefix":"10.1007","author":[{"given":"Mical","family":"Paul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oren","family":"Zusman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Leibovici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,31]]},"reference":[{"key":"11_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1469-0691.2011.03734.x","volume":"18","author":"D Yahav","year":"2012","unstructured":"Yahav D, Farbman L, Leibovici L et al (2012) Colistin: new lessons on an old antibiotic. Clin Microbiol Infect 18:18\u201329","journal-title":"Clin Microbiol Infect"},{"key":"11_CR2","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ijid.2006.09.011","volume":"11","author":"P Koomanachai","year":"2007","unstructured":"Koomanachai P, Tiengrim S, Kiratisin P et al (2007) Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand. Int J Infect Dis 11:402\u2013406","journal-title":"Int J Infect Dis"},{"key":"11_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3346\/jkms.2011.26.3.325","volume":"26","author":"SK Lim","year":"2011","unstructured":"Lim SK, Lee SO, Choi SH et al (2011) The outcomes of using colistin for treating multidrug resistant Acinetobacter species bloodstream infections. J Korean Med Sci 26:325\u2013331","journal-title":"J Korean Med Sci"},{"key":"11_CR4","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1128\/AAC.06268-11","volume":"56","author":"ZA Qureshi","year":"2012","unstructured":"Qureshi ZA, Paterson DL, Potoski BA et al (2012) Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother 56:2108\u20132113","journal-title":"Antimicrob Agents Chemother"},{"key":"11_CR5","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jinf.2008.04.002","volume":"56","author":"AP Betrosian","year":"2008","unstructured":"Betrosian AP, Frantzeskaki F, Xanthaki A et al (2008) Efficacy and safety of high-dose ampicillin\/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia. J Infect 56:432\u2013436","journal-title":"J Infect"},{"key":"11_CR6","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.2169\/internalmedicine.50.4270","volume":"50","author":"N Durakovic","year":"2011","unstructured":"Durakovic N, Radojcic V, Boban A et al (2011) Efficacy and safety of colistin in the treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in patients with hematologic malignancy: a matched pair analysis. Intern Med 50:1009\u20131013","journal-title":"Intern Med"},{"key":"11_CR7","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1086\/374337","volume":"36","author":"J Garnacho-Montero","year":"2003","unstructured":"Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez FJ et al (2003) Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 36:1111\u20131118","journal-title":"Clin Infect Dis"},{"key":"11_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2334-9-26","volume":"9","author":"R Gounden","year":"2009","unstructured":"Gounden R, Bamford C, van Zyl-Smit R et al (2009) Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections. BMC Infect Dis 9:26","journal-title":"BMC Infect Dis"},{"key":"11_CR9","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1128\/AAC.01015-06","volume":"51","author":"RY Hachem","year":"2007","unstructured":"Hachem RY, Chemaly RF, Ahmar CA et al (2007) Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients. Antimicrob Agents Chemother 51:1905\u20131911","journal-title":"Antimicrob Agents Chemother"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1007\/s00134-007-0675-2","volume":"33","author":"H Kallel","year":"2007","unstructured":"Kallel H, Hergafi L, Bahloul M et al (2007) Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study. Intensive Care Med 33:1162\u20131167","journal-title":"Intensive Care Med"},{"key":"11_CR11","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.ajic.2011.12.014","volume":"40","author":"K Ku","year":"2012","unstructured":"Ku K, Pogue JM, Moshos J et\u00a0al (2012) Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and\/or carbapenem-resistant Enterobacteriaceae infections. Am J Infect Control 40:983\u2013987","journal-title":"Am J Infect Control"},{"key":"11_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/jac\/dkq390","volume":"66","author":"CH Kvitko","year":"2011","unstructured":"Kvitko CH, Rigatto MH, Moro AL et al (2011) Polymyxin B versus other antimicrobials for the treatment of pseudomonas aeruginosa bacteraemia. J Antimicrob Chemother 66:175\u2013179","journal-title":"J Antimicrob Chemother"},{"key":"11_CR13","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/jac\/dkn128","volume":"61","author":"MS Oliveira","year":"2008","unstructured":"Oliveira MS, Prado GV, Costa SF et al (2008) Ampicillin\/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp. J Antimicrob Chemother 61:1369\u20131375","journal-title":"J Antimicrob Chemother"},{"key":"11_CR14","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/jac\/dkq069","volume":"65","author":"M Paul","year":"2010","unstructured":"Paul M, Bishara J, Levcovich A et al (2010) Effectiveness and safety of colistin: prospective comparative cohort study. J Antimicrob Chemother 65:1019\u20131027","journal-title":"J Antimicrob Chemother"},{"key":"11_CR15","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1007\/s00134-005-2691-4","volume":"31","author":"R Reina","year":"2005","unstructured":"Reina R, Estenssoro E, Saenz G et al (2005) Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study. Intensive Care Med 31:1058\u20131065","journal-title":"Intensive Care Med"},{"key":"11_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s15010-012-0349-z","volume":"41","author":"MH Rigatto","year":"2013","unstructured":"Rigatto MH, Ribeiro VB, Konzen D et al (2013) Comparison of polymyxin B with other antimicrobials in the treatment of ventilator-associated pneumonia and tracheobronchitis caused by Pseudomonas aeruginosa or Acinetobacter baumannii. Infection 41:321\u2013328","journal-title":"Infection"},{"key":"11_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1183\/09031936.00156906","volume":"30","author":"FG Rios","year":"2007","unstructured":"Rios FG, Luna CM, Maskin B et al (2007) Ventilator-associated pneumonia due to colistin susceptible-only microorganisms. Eur Respir J 30:307\u2013313","journal-title":"Eur Respir J"},{"key":"11_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1469-0691.2011.03667.x","volume":"18","author":"W Couet","year":"2012","unstructured":"Couet W, Gregoire N, Marchand S et al (2012) Colistin pharmacokinetics: the fog is lifting. Clin Microbiol Infect 18:30\u201339","journal-title":"Clin Microbiol Infect"},{"key":"11_CR19","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1128\/AAC.01361-08","volume":"53","author":"D Plachouras","year":"2009","unstructured":"Plachouras D, Karvanen M, Friberg LE et al (2009) Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. Antimicrob Agents Chemother 53:3430\u20133436","journal-title":"Antimicrob Agents Chemother"},{"key":"11_CR20","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/cid\/cit453","volume":"57","author":"DS Akajagbor","year":"2013","unstructured":"Akajagbor DS, Wilson SL, Shere-Wolfe KD et al (2013) Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center. Clin Infect Dis 57:1300\u20131303","journal-title":"Clin Infect Dis"},{"key":"11_CR21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.diagmicrobio.2009.07.018","volume":"65","author":"MS Oliveira","year":"2009","unstructured":"Oliveira MS, Prado GV, Costa SF et al (2009) Polymyxin B and colistimethate are comparable as to efficacy and renal toxicity. Diagn Microbiol Infect Dis 65:431\u2013434","journal-title":"Diagn Microbiol Infect Dis"},{"key":"11_CR22","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1128\/AAC.02476-13","volume":"58","author":"K Phe","year":"2014","unstructured":"Phe K, Lee Y, McDaneld PM et al (2014) In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy. Antimicrob Agents Chemother 58:2740\u20132746","journal-title":"Antimicrob Agents Chemother"},{"key":"11_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ijantimicag.2013.12.002","volume":"43","author":"FF Tuon","year":"2014","unstructured":"Tuon FF, Rigatto MH, Lopes CK et al (2014) Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium. Int J Antimicrob Agents 43:349\u2013352","journal-title":"Int J Antimicrob Agents"},{"key":"11_CR24","doi-asserted-by":"publisher","first-page":"R204","DOI":"10.1186\/cc2872","volume":"8","author":"R Bellomo","year":"2004","unstructured":"Bellomo R, Ronco C, Kellum JA et al (2004) Acute renal failure\u00a0\u2013 definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204\u2013R212","journal-title":"Crit Care"},{"key":"11_CR25","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1128\/AAC.01230-13","volume":"57","author":"O Zusman","year":"2013","unstructured":"Zusman O, Avni T, Leibovici L et al (2013) Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems. Antimicrob Agents Chemother 57:5104\u20135111","journal-title":"Antimicrob Agents Chemother"},{"key":"11_CR26","doi-asserted-by":"crossref","unstructured":"Paul M, Carmeli Y, Durante-Mangoni E et al (2014) Combination therapy for carbapenem-resistant gram-negative bacteria. J Antimicrob Chemother","DOI":"10.1093\/jac\/dku168"},{"key":"11_CR27","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1017\/S095026881200194X","volume":"141","author":"H Aydemir","year":"2013","unstructured":"Aydemir H, Akduman D, Piskin N et al (2013) Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia. Epidemiol Infect 141:1214\u20131222","journal-title":"Epidemiol Infect"},{"key":"11_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/cid\/cit253","volume":"57","author":"E Durante-Mangoni","year":"2013","unstructured":"Durante-Mangoni E, Signoriello G, Andini R et al (2013) Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial. Clin Infect Dis 57:349\u2013358","journal-title":"Clin Infect Dis"},{"issue":"4","key":"11_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1473-3099(18)30099-9","volume":"18","author":"Mical Paul","year":"2018","unstructured":"Paul M, Daikos GL, Durante-Mangoni E et al (2018) Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial., Lancet Infect Dis 18(4):391\u2013400. \n                  https:\/\/doi.org\/10.1016\/S1473-3099(18)30099-9","journal-title":"The Lancet Infectious Diseases"},{"issue":"8","key":"11_CR30","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s10096-014-2070-6","volume":"33","author":"A Batirel","year":"2014","unstructured":"Batirel A, Balkan II, Karabay O et al (2014) Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections. Eur J Clin Microbiol Infect Dis 33(8):1311\u20131322. \n                  https:\/\/doi.org\/10.1007\/s10096-014-2070-6","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"11_CR31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1399-3062.2011.00688.x","volume":"14","author":"MD Bergamasco","year":"2012","unstructured":"Bergamasco MD, Barroso Barbosa M, de Oliveira Garcia D et al (2012) Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation. Transpl Infect Dis 14:198\u2013205","journal-title":"Transpl Infect Dis"},{"key":"11_CR32","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1128\/AAC.02166-13","volume":"58","author":"GL Daikos","year":"2014","unstructured":"Daikos GL, Tsaousi S, Tzouvelekis LS et al (2014) Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of Carbapenems. Antimicrob Agents Chemother 58:2322\u20132328","journal-title":"Antimicrob Agents Chemother"},{"key":"11_CR33","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1111\/j.1469-0691.2006.01559.x","volume":"12","author":"ME Falagas","year":"2006","unstructured":"Falagas ME, Rafailidis PI, Kasiakou SK et al (2006) Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant gram-negative bacterial infections. Clin Microbiol Infect 12:1227\u20131230","journal-title":"Clin Microbiol Infect"},{"key":"11_CR34","doi-asserted-by":"publisher","first-page":"E72","DOI":"10.1111\/1469-0691.12091","volume":"19","author":"C Navarro-San Francisco","year":"2013","unstructured":"Navarro-San Francisco C, Mora-Rillo M, Romero-Gomez MP et al (2013) Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge. Clin Microbiol Infect 19:E72\u2013E79","journal-title":"Clin Microbiol Infect"},{"key":"11_CR35","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1086\/528719","volume":"46","author":"M Souli","year":"2008","unstructured":"Souli M, Kontopidou FV, Papadomichelakis E et al (2008) Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital. Clin Infect Dis 46:847\u2013854","journal-title":"Clin Infect Dis"},{"key":"11_CR36","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jinf.2013.04.003","volume":"67","author":"FF Tuon","year":"2013","unstructured":"Tuon FF, Rocha JL, Arend LN et al (2013) Treatment and outcome of nine cases of KPC-producing Klebsiella pneumoniae meningitis. J Infect 67:161\u2013164","journal-title":"J Infect"},{"issue":"1","key":"11_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s15010-013-0495-y","volume":"42","author":"G. Kalin","year":"2013","unstructured":"Kalin G, Alp E, Akin A et al (2013) Comparison of colistin and colistin\/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia. Infect 42:37\u201342","journal-title":"Infection"},{"key":"11_CR38","doi-asserted-by":"publisher","first-page":"O117","DOI":"10.1111\/1469-0691.12341","volume":"20","author":"F Kontopidou","year":"2014","unstructured":"Kontopidou F, Giamarellou H, Katerelos P et al (2014) Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options. Clin Microbiol Infect 20:O117\u2013O123","journal-title":"Clin Microbiol Infect"},{"key":"11_CR39","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/ALN.0b013e31827515de","volume":"117","author":"Q Lu","year":"2012","unstructured":"Lu Q, Luo R, Bodin L et al (2012) Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Anesthesiology 117:1335\u20131347","journal-title":"Anesthesiology"},{"key":"11_CR40","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/1471-2334-11-317","volume":"11","author":"R Naesens","year":"2011","unstructured":"Naesens R, Vlieghe E, Verbrugghe W et al (2011) A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa. BMC Infect Dis 11:317","journal-title":"BMC Infect Dis"},{"key":"11_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ppul.21324","volume":"46","author":"N Nakwan","year":"2011","unstructured":"Nakwan N, Wannaro J, Thongmak T et al (2011) Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: a preliminary report. Pediatr Pulmonol 46:60\u201366","journal-title":"Pediatr Pulmonol"},{"key":"11_CR42","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1093\/jac\/dkq360","volume":"65","author":"P Rattanaumpawan","year":"2010","unstructured":"Rattanaumpawan P, Lorsutthitham J, Ungprasert P et al (2010) Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by gram-negative bacteria. J Antimicrob Chemother 65:2645\u20132649","journal-title":"J Antimicrob Chemother"},{"key":"11_CR43","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1086\/657242","volume":"51","author":"DP Kofteridis","year":"2010","unstructured":"Kofteridis DP, Alexopoulou C, Valachis A et al (2010) Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study. Clin Infect Dis 51:1238\u20131244","journal-title":"Clin Infect Dis"},{"key":"11_CR44","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1378\/chest.13-1018","volume":"144","author":"M Tumbarello","year":"2013","unstructured":"Tumbarello M, De Pascale G, Trecarichi EM et al (2013) Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria. Chest 144:1768\u20131775","journal-title":"Chest"},{"key":"11_CR45","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s10156-012-0430-7","volume":"18","author":"G Kalin","year":"2012","unstructured":"Kalin G, Alp E, Coskun R et al (2012) Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment? J Infect Chemother 18:872\u2013877","journal-title":"J Infect Chemother"},{"key":"11_CR46","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/j.1469-0691.2009.03040.x","volume":"16","author":"IP Korbila","year":"2010","unstructured":"Korbila IP, Michalopoulos A, Rafailidis PI et al (2010) Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study. Clin Microbiol Infect 16:1230\u20131236","journal-title":"Clin Microbiol Infect"},{"key":"11_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ijantimicag.2009.09.014","volume":"35","author":"DM Livermore","year":"2010","unstructured":"Livermore DM, Hill RL, Thomson H et al (2010) Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London. Int J Antimicrob Agents 35:19\u201324","journal-title":"Int J Antimicrob Agents"}],"container-title":["Advances in Experimental Medicine and Biology","Polymyxin Antibiotics: From Laboratory Bench to Bedside"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-16373-0_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T15:12:37Z","timestamp":1564499557000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-16373-0_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030163716","9783030163730"],"references-count":47,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-16373-0_11","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"31 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}